Competing Risk of Death and ESRD in Incident CKD Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

631 participants

Study Classification

OBSERVATIONAL

Study Start Date

2004-01-01

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Although chronic kidney disease (CKD) affects a growing number of people, epidemiologic data on incident CKD in the general population are scarce. Screening strategies to increase early CKD detection have been developed.

Methods: From a community-based sample of 4,409 individuals residing in a well-defined geographical area, investigators determined the number of patients having a first serum creatinine value ≥1.7 mg/dL and present for at least 3 months that allowed us to calculate an annual incidence rate of CKD (stages 3 to 5). CKD (stages 3 to 5) was defined by estimated glomerular filtration rate (eGFR) \<60 mL/min/1.73 m2. Investigators also described the primary care, outcomes and risk factors associated with outcomes using competing risks analyses for these CKD patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Kidney Diseases

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Chronic kidney disease Competing-risk analysis Epidemiological study Incidence Outcomes Risk factors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \>= 18 years
* first serum creatinine value ≥1.7 mg/dL reached after January 1st, 2004
* and present for at least 3 months
* residing in the given geographical area (the Urban Community of Greater Nancy (UCGN))

Exclusion Criteria

* \<18 years
* prevalent CKD patient : CKD diagnosis before January 1st, 2004
* patients on dialysis or renal transplanted
* refusal of participation

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michèle KESSLER, PU-PH

Role: PRINCIPAL_INVESTIGATOR

CHRU de Nancy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EPIRAN1

Identifier Type: -

Identifier Source: org_study_id